Literature DB >> 22364721

Pulmonary hypertension in canine degenerative mitral valve disease.

Heidi B Kellihan1, Rebecca L Stepien.   

Abstract

Pulmonary hypertension secondary to degenerative mitral valve disease has been recognized clinically for many years in veterinary medicine, and clinical diagnosis of this syndrome in dogs has been enhanced greatly by widespread use of echocardiography and Doppler echocardiography. Medical therapy is now available to treat this clinical complication of mitral valve disease, making timely diagnosis even more important to patient longevity and quality of life. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22364721     DOI: 10.1016/j.jvc.2012.01.001

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  29 in total

1.  Pulmonary arterial strain- and remodeling-induced stiffening are differentiated in a chronic model of pulmonary hypertension.

Authors:  Mark J Golob; Diana M Tabima; Gregory D Wolf; James L Johnston; Omid Forouzan; Ashley M Mulchrone; Heidi B Kellihan; Melissa L Bates; Naomi C Chesler
Journal:  J Biomech       Date:  2017-02-21       Impact factor: 2.712

2.  Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study.

Authors:  J A Jaffey; S B Leach; L R Kong; K E Wiggen; S B Bender; C R Reinero
Journal:  J Vet Cardiol       Date:  2019-05-11       Impact factor: 1.701

3.  Accuracy of Doppler echocardiographic estimates of pulmonary artery pressures in a canine model of pulmonary hypertension.

Authors:  Lydia C Soydan; Heidi B Kellihan; Melissa L Bates; Rebecca L Stepien; Daniel W Consigny; Alessandro Bellofiore; Christopher J Francois; Naomi C Chesler
Journal:  J Vet Cardiol       Date:  2015-01-16       Impact factor: 1.701

4.  Predictive model for the detection of pulmonary hypertension in dogs with myxomatous mitral valve disease.

Authors:  Shoma Mikawa; Yuichi Miyagawa; Noriko Toda; Yoshinori Tominaga; Naoyuki Takemura
Journal:  J Vet Med Sci       Date:  2014-10-16       Impact factor: 1.267

5.  Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease.

Authors:  M Borgarelli; J Abbott; L Braz-Ruivo; D Chiavegato; S Crosara; K Lamb; I Ljungvall; M Poggi; R A Santilli; J Haggstrom
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

6.  Utility of Tissue Doppler Imaging in the Echocardiographic Evaluation of Left and Right Ventricular Function in Dogs with Myxomatous Mitral Valve Disease with or without Pulmonary Hypertension.

Authors:  M Baron Toaldo; H Poser; G Menciotti; S Battaia; B Contiero; M Cipone; A Diana; E Mazzotta; C Guglielmini
Journal:  J Vet Intern Med       Date:  2016-05       Impact factor: 3.333

7.  Diagnostic Value of Right Pulmonary Artery Distensibility Index in Dogs with Pulmonary Hypertension: Comparison with Doppler Echocardiographic Estimates of Pulmonary Arterial Pressure.

Authors:  L C Visser; M K Im; L R Johnson; J A Stern
Journal:  J Vet Intern Med       Date:  2016-02-19       Impact factor: 3.333

8.  Non-invasive Assessment of Pulmonary Artery Wave Reflection in Dogs With Suspected Pulmonary Hypertension.

Authors:  Tomohiko Yoshida; Katsuhiro Matsuura; Goya Seijirow; Akiko Uemura; Zeki Yilmaz; Ryou Tanaka
Journal:  Front Vet Sci       Date:  2021-07-09

9.  Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease.

Authors:  A Tidholm; K Höglund; J Häggström; I Ljungvall
Journal:  J Vet Intern Med       Date:  2015-09-14       Impact factor: 3.333

10.  Correlation between caudal pulmonary artery diameter to body surface area ratio and echocardiography-estimated systolic pulmonary arterial pressure in dogs.

Authors:  Youngjae Lee; Wooshin Choi; Donghoon Lee; Jinhwa Chang; Ji-Houn Kang; Jihye Choi; Dongwoo Chang
Journal:  J Vet Sci       Date:  2016-06-30       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.